Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization
- PMID: 11165263
- DOI: 10.1016/s0014-5793(01)02110-x
Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization
Abstract
Retinal levels of vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF), an angiogenic inhibitor, were measured and correlated with the ischemia-induced retinal neovascularization in rats. The retinas with neovascularization showed a 5-fold increase in VEGF while 2-fold decrease in PEDF, compared to the age-matched controls, resulting in an increased VEGF/PEDF ratio. The time course of the VEGF/PEDF ratio change correlated with the progression of retinal neovascularization. Changes in the VEGF and PEDF mRNAs preceded their protein level changes. These results suggest that an unbalance between angiogenic stimulators and inhibitors may contribute to retinal neovascularization.
Similar articles
-
Difference in ischemic regulation of vascular endothelial growth factor and pigment epithelium--derived factor in brown norway and sprague dawley rats contributing to different susceptibilities to retinal neovascularization.Diabetes. 2002 Apr;51(4):1218-25. doi: 10.2337/diabetes.51.4.1218. Diabetes. 2002. PMID: 11916948
-
Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization.Invest Ophthalmol Vis Sci. 2002 Apr;43(4):1168-75. Invest Ophthalmol Vis Sci. 2002. PMID: 11923262
-
Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.Invest Ophthalmol Vis Sci. 2002 Mar;43(3):821-9. Invest Ophthalmol Vis Sci. 2002. PMID: 11867604
-
Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions.Clin Biochem. 2006 Mar;39(3):267-76. doi: 10.1016/j.clinbiochem.2005.11.013. Epub 2006 Jan 10. Clin Biochem. 2006. PMID: 16409998 Review.
-
Vascular endothelial growth factor: molecular underpinning from development of vasculature to development of disease.Am J Physiol Cell Physiol. 2001 Jun;280(6):C1357. doi: 10.1152/ajpcell.2001.280.6.C1357. Am J Physiol Cell Physiol. 2001. PMID: 11350729 Review. No abstract available.
Cited by
-
Antiangiogenic therapy in diabetic nephropathy: A double‑edged sword (Review).Mol Med Rep. 2021 Apr;23(4):260. doi: 10.3892/mmr.2021.11899. Epub 2021 Feb 8. Mol Med Rep. 2021. PMID: 33655322 Free PMC article. Review.
-
Bruch's Membrane and the Choroid in Age-Related Macular Degeneration.Adv Exp Med Biol. 2021;1256:89-119. doi: 10.1007/978-3-030-66014-7_4. Adv Exp Med Biol. 2021. PMID: 33847999
-
Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema.Int J Mol Sci. 2021 Mar 26;22(7):3427. doi: 10.3390/ijms22073427. Int J Mol Sci. 2021. PMID: 33810434 Free PMC article. Review.
-
Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model.Diabetologia. 2006 Jul;49(7):1690-701. doi: 10.1007/s00125-006-0274-8. Epub 2006 May 10. Diabetologia. 2006. PMID: 16752188
-
Expression of pigment epithelium-derived factor and vascular endothelial growth factor in fibrovascular membranes from patients with proliferative diabetic retinopathy.Jpn J Ophthalmol. 2006 Mar-Apr;50(2):116-20. doi: 10.1007/s10384-005-0294-9. Jpn J Ophthalmol. 2006. PMID: 16604386
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous